Vanguard Group
BBIO icon

Vanguard Group’s BridgeBio Pharma BBIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$712M Buy
16,484,985
+1,584,840
+11% +$68.4M 0.01% 831
2025
Q1
$515M Sell
14,900,145
-177,770
-1% -$6.15M 0.01% 974
2024
Q4
$414M Buy
15,077,915
+879,059
+6% +$24.1M 0.01% 1151
2024
Q3
$362M Buy
14,198,856
+144,108
+1% +$3.67M 0.01% 1219
2024
Q2
$356M Buy
14,054,748
+832,622
+6% +$21.1M 0.01% 1164
2024
Q1
$409M Buy
13,222,126
+421,832
+3% +$13M 0.01% 1109
2023
Q4
$517M Buy
12,800,294
+1,524,313
+14% +$61.5M 0.01% 951
2023
Q3
$297M Sell
11,275,981
-409,016
-4% -$10.8M 0.01% 1212
2023
Q2
$201M Sell
11,684,997
-378,259
-3% -$6.51M ﹤0.01% 1472
2023
Q1
$200M Buy
12,063,256
+1,471,801
+14% +$24.4M 0.01% 1456
2022
Q4
$80.7M Buy
10,591,455
+587,184
+6% +$4.47M ﹤0.01% 1923
2022
Q3
$99.4M Buy
10,004,271
+108,734
+1% +$1.08M ﹤0.01% 1787
2022
Q2
$89.9M Buy
9,895,537
+471,425
+5% +$4.28M ﹤0.01% 1889
2022
Q1
$95.7M Buy
9,424,112
+92,429
+1% +$938K ﹤0.01% 1966
2021
Q4
$156M Sell
9,331,683
-103,729
-1% -$1.73M ﹤0.01% 1745
2021
Q3
$442M Sell
9,435,412
-1,893,717
-17% -$88.8M 0.01% 1050
2021
Q2
$691M Buy
11,329,129
+1,987,943
+21% +$121M 0.02% 800
2021
Q1
$575M Buy
9,341,186
+2,899,874
+45% +$179M 0.02% 871
2020
Q4
$458M Buy
6,441,312
+146,194
+2% +$10.4M 0.01% 925
2020
Q3
$236M Buy
6,295,118
+508,600
+9% +$19.1M 0.01% 1173
2020
Q2
$189M Buy
5,786,518
+3,417,387
+144% +$111M 0.01% 1307
2020
Q1
$68.7M Buy
2,369,131
+228,135
+11% +$6.62M ﹤0.01% 1710
2019
Q4
$75M Buy
2,140,996
+548,046
+34% +$19.2M ﹤0.01% 1908
2019
Q3
$34.2M Buy
1,592,950
+1,505,668
+1,725% +$32.3M ﹤0.01% 2241
2019
Q2
$2.35M Buy
+87,282
New +$2.35M ﹤0.01% 3426